| 日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
| 11/02/2026 | CHING NGAI INDUSTRIES (CHINA) COMPANY LIMITED | 1201(L) | -2,930,000(L) | 14,575,688(L) | 4.21 | |
| 05/02/2026 | LVC Management Holdings Limited | 1704(L) | 11,690,752(L) | 11,690,752(L) | 3.38 | |
| 05/02/2026 | Golden Valley Value Select Master Fund | 1704(L) | 11,690,752(L) | 11,690,752(L) | 3.38 | |
| 05/02/2026 | Vistra Trust (Singapore) Pte. Limited | 1704(L) | 11,690,752(L) | 11,690,752(L) | 3.38 | |
| 05/02/2026 | LVC SG MANAGEMENT PTE. LTD. | 1704(L) | 11,690,752(L) | 11,690,752(L) | 3.38 | |
| 04/02/2026 | Fosun Holdings Limited | 1113(L) | -120,000,000(L) | 192,399,700(L) | 97.46 | |
| 04/02/2026 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1113(L) | +120,000,000(L) | 152,331,100(L) | 44.02 | |
| 04/02/2026 | 朱俊 | 1711(L) | 1,550,000(L) | 0.45 | ||
| 04/02/2026 | Shanghai Fosun New Medicine Research Company Limited | 1113(L) | -120,000,000(L) | 145,971,569(L) | 73.94 | |
| 04/02/2026 | Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. | 1113(L) | -120,000,000(L) | 192,399,700(L) | 97.46 | |
| 04/02/2026 | Fosun International Limited | 1113(L) | +120,000,000(L) | 152,331,100(L) | 44.02 | |
| 04/02/2026 | Shanghai Fosun High Technology (Group) Co., Ltd. | 1113(L) | -120,000,000(L) | 192,399,700(L) | 97.46 | |
| 04/02/2026 | Fosun International Holdings Ltd. | 1113(L) | +120,000,000(L) | 152,331,100(L) | 44.02 | |
| 04/02/2026 | Fosun Holdings Limited | 1113(L) | +120,000,000(L) | 152,331,100(L) | 44.02 | |
| 04/02/2026 | Shanghai Fosun High Technology (Group) Co., Ltd. | 1113(L) | +120,000,000(L) | 152,331,100(L) | 44.02 | |
| 04/02/2026 | Fosun International Limited | 1113(L) | -120,000,000(L) | 192,399,700(L) | 97.46 | |
| 04/02/2026 | Morgan Stanley | 1704(L) | -820,646(L) | 7,958,399(L) 322,431(S) 0(P) | 2.29 0.09 0.00 | |
| 04/02/2026 | Boyu Capital Investment Management Limited | 1704(L) | 12,149,900(L) | 3.51 | ||
| 04/02/2026 | Boyu Capital Group Holdings Ltd. | 1704(L) | 12,149,900(L) | 3.51 | ||
| 04/02/2026 | CHING NGAI INDUSTRIES (CHINA) COMPANY LIMITED | 1013(L) | +17,505,688(L) | 17,505,688(L) | 5.06 | |
| 04/02/2026 | Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. | 1013(L) | +120,000,000(L) | 120,000,000(L) | 34.67 | |
| 04/02/2026 | GIC Private Limited | 1704(L) | 11,890,400(L) | 3.44 | ||
| 04/02/2026 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1113(L) | -120,000,000(L) | 192,399,700(L) | 97.46 | |
| 04/02/2026 | Taikang Insurance Group, Inc. | 1704(L) | 10,321,800(L) | 2.98 | ||
| 04/02/2026 | XYXY Holdings Ltd. | 1704(L) | 12,149,900(L) | 3.51 | ||
| 04/02/2026 | 童小幪 | 1704(L) | 12,149,900(L) | 3.51 | ||
| 04/02/2026 | 郭广昌 | 1113(L) | +120,000,000(L) | 152,331,100(L) | 44.02 | |
| 04/02/2026 | Boyu Group, LLC | 1704(L) | 12,149,900(L) | 3.51 | ||
| 04/02/2026 | Fosun International Holdings Ltd. | 1113(L) | -120,000,000(L) | 192,399,700(L) | 97.46 | |
| 04/02/2026 | Fosun Industrial Co., Limited | 1213(L) | 32,331,100(L) | 9.34 | ||
| 04/02/2026 | Shanghai Fosun New Medicine Research Company Limited | 1013(L) | +120,000,000(L) | 120,000,000(L) | 34.67 | |
| 04/02/2026 | 郭广昌 | 1113(L) | -120,000,000(L) | 192,399,700(L) | 97.46 | |
| 30/01/2026 | UBS Group AG | 1704(L) | -2,168,815(L) | 6,406,642(L) 4,707,918(S) | 3.92 2.88 | |
| 29/01/2026 | Morgan Stanley | 1013(L) | +883,745(L) | 8,686,133(L) 305,828(S) 0(P) | 5.31 0.18 0.00 | |
| 29/01/2026 | UBS Group AG | 1113(L) 1402(S) | +354,068(L) +3,690,259(S) | 8,302,498(L) 4,425,159(S) | 5.08 2.71 | |
| 28/01/2026 | Morgan Stanley | 1704(L) | -467,557(L) | 7,802,388(L) 305,728(S) 0(P) | 4.77 0.18 0.00 | |
| 28/01/2026 | UBS Group AG | 1704(L) | -640,924(L) | 7,956,630(L) | 4.87 | |
| 20/01/2026 | UBS Group AG | 1306(L) | 115,581(L) | 8,553,254(L) | 5.23 | |
| 14/01/2026 | GIC Private Limited | 1101(L) | +38,300(L) | HKD67.546(L) | 11,444,300(L) | 7.00 |
| 13/01/2026 | Morgan Stanley | 1312(L) | 15,560(L) | 8,575,541(L) 692,588(S) 0(P) | 5.24 0.42 0.00 | |
| 1 2 3 4 5 | ||||||
| 备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
| (S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
| (P) - 可供借出的股份 | |
| 即时报价更新时间为 16/02/2026 17:59 | |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |